Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PARP-1-IN-2 is a potent PARP1 inhibitor that crosses the blood-brain barrier (IC50: 149 nM).PARP-1-IN-2 showed significant antiproliferative activity against the human lung adenocarcinoma epithelial cell line A549 in cellular assays.PARP-1-IN-2 induced apoptosis in A549 cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 98.00 | |
5 mg | In stock | $ 247.00 | |
10 mg | In stock | $ 397.00 | |
25 mg | In stock | $ 663.00 | |
50 mg | In stock | $ 945.00 | |
100 mg | In stock | $ 1,280.00 | |
500 mg | In stock | $ 2,570.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 262.00 |
Description | PARP-1-IN-2 is a potent PARP1 inhibitor that crosses the blood-brain barrier (IC50: 149 nM).PARP-1-IN-2 showed significant antiproliferative activity against the human lung adenocarcinoma epithelial cell line A549 in cellular assays.PARP-1-IN-2 induced apoptosis in A549 cells. |
Targets&IC50 | PARP1:149 ± 11.0 nM |
In vitro |
PARP-1-IN-2 (compound 11g) (0-10 μM, 24-48 h) significantly anti-proliferative activity against A549 cells and didn’t display any significant cytotoxicity on HFF cells.[1] PARP-1-IN-2 (0-10 μM, 24 h) decreases the expression of pro-caspase-3 and phosphorylated AKT increases the expression of caspase-3, caspase-9 protein, and the cleaved PARP-1.[1] |
Molecular Weight | 424.28 |
Formula | C22H15Cl2N3O2 |
CAS No. | 684234-55-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 75.0 mg/mL (176.8 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PARP-1-IN-2 684234-55-7 Chromatin/Epigenetic DNA Damage/DNA Repair PARP inhibitor inhibit